➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Dow
AstraZeneca
Express Scripts
Johnson and Johnson

Last Updated: June 25, 2021

DrugPatentWatch Database Preview

SOLIRIS Drug Profile


Email this page to a colleague

« Back to Dashboard

Recent Clinical Trials for SOLIRIS

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Cedars-Sinai Medical CenterPhase 2
Assistance Publique - Hôpitaux de ParisPhase 2
Johns Hopkins UniversityPhase 1

See all SOLIRIS clinical trials

Recent Litigation for SOLIRIS

Identify key patents and potential future biosimilar entrants

PTAB Litigation
PetitionerDate
Amgen Inc.2019-02-28
Amgen, Inc.2019-02-28
2017-12-20

See all SOLIRIS litigation

Pharmacology for SOLIRIS
Mechanism of ActionComplement Inhibitors

Company Disclosures: US Patents for SOLIRIS

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16   Get Started Free Alexion Pharmaceuticals, Inc. (Cheshire, CT) 2019-03-12 RX Orphan company
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16   Get Started Free Alexion Pharmaceuticals, Inc. (New Haven, CT) 2027-03-15 RX Orphan company
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16   Get Started Free Alexion Pharmaceuticals, Inc. (New Haven, CT) 2027-03-15 RX Orphan company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for SOLIRIS

These patents were identified by searching patent claims

International Patents for SOLIRIS

Country Patent Number Estimated Expiration
European Patent Office 2358760   Get Started Free
Russian Federation 2017118985   Get Started Free
Australia 2015230852   Get Started Free
Russian Federation 2718850   Get Started Free
Australia 2014306002   Get Started Free
Mexico 2009002388   Get Started Free
European Patent Office 2386317   Get Started Free
>Country >Patent Number >Estimated Expiration

Supplementary Protection Certificates for SOLIRIS

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2010C/010 Belgium   Get Started Free PRODUCT NAME: ECULIZUMAB; AUTHORISATION NUMBER AND DATE: EU/1/07/393/001 20070620
132010901820871 Italy   Get Started Free PRODUCT NAME: ECULIZUMAB(SOLIRIS); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/07/393/001, 20070620
SZ 12/2010 Austria   Get Started Free PRODUCT NAME: ECULIZUMAB
12/2010 Austria   Get Started Free PRODUCT NAME: ECULIZUMAB; REGISTRATION NO/DATE: EU/1/07/393/001 20070620
SPC002/2010 Ireland   Get Started Free SPC002/2010: 20100902, EXPIRES: 20200430
C00758904/01 Switzerland   Get Started Free FORMER REPRESENTATIVE: VOSSIUS AND PARTNER, CH
122009000075 Germany   Get Started Free PRODUCT NAME: ECULIZUMAB; REGISTRATION NO/DATE: EU/1/07/393/001 20070620
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
AstraZeneca
Medtronic
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.